2000, Number 2
<< Back
Microbiología 2000; 42 (2)
Viral mechanisms of Apoptosis blockade as an evasion strategy of immunological response.
Chacón-Salinas R, Sánchez-Cruz P
Language: Spanish
References: 80
Page: 83-93
PDF size: 98.48 Kb.
ABSTRACT
In response to viral infections the host uses several immunological mechanisms to defend oneself. Apoptosis stand out by its protagonist role in the control of these infections like an effector mecha-nism of both innate and acquired immune response. However, some viruses block apoptosis with the purpose to avoid its elimination through the immune response. In this way, viruses has genes that code proteins with anti-apoptotic functions that modulate the expression or function of cellular proteins that regulate this process. In the innate apoptosis the blockade occurs at three inhibition or inactivation levels like mitochondrial membrane alteration, PKR and p53; while the blockade of apoptosis in the acquired immune response occurs by: inhibition of granzyme B, inhibition of interaction of CD95-FasL, inhibition of DISC formation and inhi bition of caspases. The knowledge of cellular mechanisms of apoptosis induction during viral infections and mainly the strategies of blockade of this process by viruses is fundamental in the design of therapies for control and eradication of this kind of infections.
REFERENCES
Afonso, C. L., J. G. Neilan, G. F. Kutish and D. L. Rock. 1996. An African swine fever virus Bcl-2 homolog, 5-HL, suppresses apoptotic cell death. J. Virol. 70:4858-4863.
Akaike, T., M. Suga and H. Maeda. 1998. Free radicals in viral pathogenesis: molecular mechanisms involving superoxide and NO. Proc. Soc. Exp. Biol. Med. 217:64-73.
Balachandran, S., C. N. Kim, W. C. Yeh, T. W. Mark, K. Bhalla and G. N. Barber. 1998. Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling. EMBO J. 17:6888-6902.
Balthesen, M., M. Messerle and J. Reddehase. 1993. Lungs are a major organ site of cytomegalovirus latency and recurrence. J. Virol. 67:5360-5366.
Beidler, D. R., M. Tewari, P. D. Friesen, G. Poirier and V. M. Dixit. 1995. The baculovirus p35 protein inhibits Fas- and tumor necrosis factor-induced apoptosis. J. Biol. Chem. 270:16526-16528.
Berke, G. 1995. The CTL’s kiss of death. Cell. 81:9-12.
Berndt, C., B. Möps, S. Angermüller, P. Gierschick and P. H. Krammer. 1998. CXCR4 and CD4 mediate a rapid CD95-independent cell death in CD4+ T cells. Proc. Natl. Acad. Sci. USA. 95:12556-12561.
Bertin, J., R. C. Armstrong, S. Ottilie, D. A. Martin, Y. Wang, S. Banks, G. H. Yang, T. G. Senkevich, E. S. Alnemri, B. Moss, M. J. Lenardo, K. J. Tomaselli and J. I. Cohen. 1997. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas and TNFR1-induced apoptosis. Proc. Natl. Acad. Sci. USA 94:1172-1176.
Bonzon, C. and H. Fan. 1999. Moloney murine leukemia virus-induced preleukemic thymic atrophy and enhanced thymocyte apoptosis correlate with disease pathogencity. J. Virol. 73:2434-2441.
Bump, N. J., M. Hackett, M. Hugunin, S. Seshagiri, K. Brady, P. Chen, C. Ferenz, S. Franklin, T. Ghayur, P. Li, P. Licari, J. Mankovich, L. Shi, A. H. Greenberg, L. K. Miller and W. W. Wong. 1995. Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science. 269:1885-1888.
Carroll, K., O. Elroy-Stein, R. Moss and R. Jagus. 1993. Recombinant vaccinia virus K3L gene product prevents activation of dsRNA dependent eIF 2 kinase. J. Biol. Chem. 268:12837-12842.
Chang, H. W., J. C. Watson and B. L. Jacobs. 1992. The E3L gene of vaccinia virus encodes and inhibition of the interferon induced, dsRNA dependent protein kinase. Proc. Natl. Acad. Sci. USA 89:4825-4829.
Chen, P., J. Tian, I. Kovesdi and J. T. Bruder. 1998. Interaction of the adenovirus 14.7 kDa protein with FLICE inhibits Fas ligand-induced apoptosis. J. Biol. Chem. 273:5815-5820.
Cheng, E. H., J. Nicholas, D. S. Bellows, G. S. Hayward, H. G. Guo, M. S. Reitz and J. M. Hardwick. 1997. A Bcl-2 homolog encoded by Kaposi sarcomaassociated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc. Natl. Acad. Sci. USA 94:690-694.
Dobbelstein, M. and T. Shenk. 1996. Protection against apoptosis by the vaccinia virus SPI-2 (B13R) gene product. J. Virol. 70:6479-6485.
Everett, H. and G. McFadden. 1999. Apoptosis: an innate immune response to virus infection. Trends Microbiol. 7:160-165.
Farrow, S. N., J. H. White, I. Martinou, T. Raven, K. T. Pun, C. J. Grinham, J. C. Marinou and R. Brown. 1995. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature 374:731-733.
Froelich, C. J., V. M. Dixit and X. Yang. 1998. Ly mphocyte granule-mediated apoptosis: matters of viral mimicry and deadly proteases. Immunol. Today 19:30- 36.
Gale, M., B. Kwiecis zewski, M. Dosset, H. Nakao and M.G. Katze. 1999. Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase. J. Virol. 73:6506-6516.
Galvan, V., R. Brandimarti and B. Roizman. 1999. Herpes simplex virus 1 blocks caspase-3-independent and caspase-dependent pathways to cell death. J Virol. 73:3219-3226.
Gottlob, K., M. Fulco, M. Levrero and A. Graessmann. 1998. The hepatitis B virus Hbx protein inhibits caspase 3 activity. J. Biol. Chem. 273:33347-33353.
Granville, D. J., C. M. Carthy, H. Jiang, G. C. Shore, B. M. McManus and D. W. Hunt. 1998. Rapid cytochrome C release, activation of caspase 3, 6, 7 and 8 followed by Bap31 cleavage in HeLa cells treated with photodynamic therapy. FEBS Lett. 437:5-10.
Green, D.R. 1998. Apoptotic pathways: the roads to ruin. Cell 94:695-698.
Guillerm, C., V. Robert-Hebmann, U. Hibner, M. Hirn and C. Devaux. 1998. An anti-CD4 (CDR3-loop) monoclonal antibody inhibits human immunodeficiency virus type 1 envelope glycoprotein-induced apoptosis. Virology 248:254-263.
Hawkins, C. J., A. G. Uren, G. Häcker, R. L. Medcalf and D. L. Vaux. 1996. Inhibition of interleukin 1b-converting enzyme -mediated apoptosis of mammalian cells by baculovirus IAP. Proc. Natl. Acad. Sci. USA 93:13786-13790.
Henderson, S., D. Huen, M. Rowe, C. Dawson, G. Johnson and A. Rickinson. 1993. Epstein-Bar viruscoded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci. USA 90:8479-8483.
Hirata, H., A. Takahashi, S. Kobayashi, S. Yonehara, H. Sawai, T. Okazaki, K. Yamamoto and M. Sasada. 1998. Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J. Exp. Med. 187:587-600.
Hu, S., C. Vincenz, M. Buller and V. M. Dixit. 1997. A novel family of viral death effector domain-containing molecules that inhibit both CD95- and tumor necrosis factor receptor-1-induced apoptosis. J. Biol. Chem. 272:9621-9624.
Imani, F. and B. L. Jacobs. 1988. Inhibitory activity for the interferon-induced protein kinase is associated with the reovirus serotype 1 sigma 3 protein. Proc. Natl. Acad. Sci. USA 85:7887-7891.
Kaplan, D. and S. Sieg. 1998. Role of the Fas/Fas ligand apoptotic pathways in human immuonodeficiency virus type I disease. J. Virol. 72:6279-6282.
Katze, M. G., D. DeCorato, B. Safer, J. Galabru and A. G. Hovanessian. 1987. Adenovirus VAI RNA complexes with the 68,000 Mr protein kinase to regulate its autophosphorylation and activity. EMBO J. 6:689-697.
Katze, M. G. 1995. Regulation of the interferon induced PKR: can viruses cope? Trends Microbiol. 3:75-78.
Kawanishi, M. 1997. Epstein-Barr virus BHRF1 protein protects intestine 407 epithelial cells from apoptosis induced by tumor necrosis factor alpha and anti- Fas antibody. J. Virol. 71:3319-3322.
Kettle, S., A. Alcamí, A. Khanna, R. Ehret, C. Jassoy and G. L. Smith. 1997. Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1b-converting enzyme and protects virus-infected cells from TNF- and Fasmediated apoptosis, but does not prevent IL-1b- induced fever. J. Gen. Virol. 78:677-685.
Klenerman, P. and R. M. Zinkarnagel. 1998. Original antigenic sin impairs cytotoxic T lymphocyte response to viruses bearing variant epitopes. Nature 394:482-485.
Kovacs, A., M. L. Weber, L. J. Burns, H. S. Jacobs and K. Vercelloti. 1996. Cytoplasmic sequestration of p53 in cytomegalovirus-infected human endothelial cells. Am. J. Pathol. 149:1531-1539.
Koyama, A. H., H. Irie, T. Fukumori, S. Hata, S. Ida, H. Akari and A. Adachi. 1998. Role of virus-induced apoptosis in a host defense mechanism against virus infection. J. Med. Invest. 45:37-45.
Meinl, E., H. Fickenscher, M. Thome, J. Tschopp and B. Fleckenstein. 1998. Anti-apoptotic strategies of ly mphotropic viruses. Immunol. Today 19:474-479.
Messud-Petit, F., J. Gelfi, M. Delverdier, M. F. Amardeilh, R. Py, G. Sutter and S. Bertagnoli. 1998. Serp2, an inhibitor of the interleukin-1beta-converting enzyme, is critical in the pathobiology of myxoma virus. J. Virol. 72:7830-7839.
Meyaard, L., S. A. Otto, R. R. Jonker, M. J. Mijnster, R. P.M. Keet and F. Miedema. 1992. Programmed death of T cells in HIV-1 infection. Science 257:217-219.
Nash, P., J. Barret, J. X. Cao, S. Hota-Mitchell, A. S. Lalani, H. Everett, X. M. Xu, J. Robichaud, S. Hnatiuk, C. Ainslie, B. T. Seet and G. McFadden. 1999. Immunomodulation by viruses: the myxoma virus story. Immunol. Rev. 168:103-120.
Nash, T. 1996. Immunity to viruses, p 16.1-16.8. En: I. Roitt, J. Brostoff and D. Male (ed.). Immunology. 4th ed. Mosby, London, England.
Nava, V. E., E. H. Cheng, M. Veliuona, S. Zou, R. J. Clem, M. L. Mayer and J. M. Hardwick. 1997. Herpesvirus saimiri encodes a functional homologous of the human bcl-2 oncogene. J. Virol. 71:4118-4122.
Neil, J. C., E. R. Cameron and E. W. Baxter. 1997. p53 and tumor viruses: catching the guardian off-guard. Trends Microbiol. 5:115-120.
Neilan, J. G., Z. Lu, C. L. Afonso, G. F. Kurtish, M. D. Sussman and D. L. Rock. 1993. An African swine fever virus gene with similarity to the proto-oncogene bcl-2 and the Epstein-Barr virus gene BHRF1. J Virol. 67:4391-4394.
Ng, F. W. H. and G. C. Shore. 1998. Bcl-XL cooperatively associates with the Bap31 complex in the endoplasmic reticulum dependent on procaspase-8 and Ced- 4 adaptor. J. Biol. Chem. 273:3140-3143.
Ohnimus, H., M. Heinkelein and C. Jassoy. 1997. Apoptotic cell death upon contact of CD4+ T lymphocytes with HIV glycoprotein-expressing cells is mediated by caspases but bypasses CD95 (Fas/Apo-1) and TNF receptor 1. J. Immunol. 159:5246-5252.
Peter, M. E. and P. H. Krammer. 1998. Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. Curr. Opinion Immunol. 10:545-551.
Pircher, H., D. Moskophidis, U. Rohrer, K. Bürki, H. Hengartner and R. M. Zinkernagel. 1990. Viral escape by selection of cytotoxic T cell-resistant variants in vivo. Nature 346:629-633.
Ploegh, H. L. 1998. Viral strategies of immune evasion. Science 280:248-253.
Quan, L. T., A. Caputo, R. C. Bleackley, D. J. Pickup and Salvesen G. S. 1995. Granzyme B is inhibited by the cowpox virus serpin cytokine response modifier A. J. Biol. Chem. 270:10377-10379.
Querido, E., R. C. Marcellus, A. Lai, R. Charbonneau, J. G. Teodoro, G. Ketner and P. E. Branton. 1997. Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf16 in adenovirus-infected cells. J. Virol. 71:3788-3798.
Raff, M. 1998. Cell suicide for beginners. Nature 396:119-122.
Ray, C. A., R. A. Black, S. R. Kronheim, T. A. Greenstreet, P. R. Sleath, G. S. Salvesen and D. J. Pickup. 1992. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin -1b converting enzyme. Cell 69:597-604.
Revilla, Y., A. Cebrian, E. Baixeras, C. Martinez, E. Vinuela and M. L. Salas. 1997. Inhibition of apoptosis by the african swine fever virus Bcl-2 homologue: role of BH1 domain. Virology 228:400-404.
Rouvier, E., M. F. Luciani and P. Golstein. 1993. Fas involvement in Ca2+-independent T cell-mediated cyototoxicity. J. Exp. Med. 177:195-200.
Roy, N., Q. L. Deveraux, R. Takahashi, G. S. Salvesen and J. C. Reed. 1997. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J. 16:6914-6925.
Roy, S., M. G. Katze, N. T. Parkin, Y. Edery, A. G. Hovanessian and N. Sonenberg. 1990. Control of the interferon induced 68-kilodalton protein kinase by the HIV-1 tat gene product. Science 247:1216-1219.
Sánchez-Cruz, P. and R. Pelayo-Camacho. 1996. Múltiples estrategias de evasión de la respuesta inmune por citomegalovirus humano: Mecanismos moleculares. Lab. Acta. 8:65-73.
Scheffner, M., J. M. Huibregtse, R. D. Vierstra and P. M. Howley. 1993. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75:495-505.
Scheffner, M., B. A. Werness, J. M. Huibregtse, A. J. Levine and P. M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136.
Schweizer, M. and E. Peterhans. 1999. Oxidative stress in cells infected with bovine viral diarrhoea virus: a crucial step in the induction of apoptosis. J. Gen. Virol. 80:1147-1155.
Shisler, J., C. Yang C, B. Walter, C. F. Ware and L. R. Gooding. 1997. The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis. J. Virol. 71:8299-8306.
Shresta, S., C. T. N. Pham, D. A. Thomas, T. A. Graubert and T. J. Ley. 1998. How do cytotoxic ly mphocytes kill their targets? Curr. Opinion Immunol. 10:581-587.
Sieg, S., L. Xia, Y. Huang and D. Kaplan. 1995. Specific inhibition of granzyme B by parainfluenza virus type 3. J. Virol. 69:3538-3541.
Sieg, S, Z. Yildrim, D. Smith, N. Kayagaki, H. Yagita, Y. Huang and D. Kaplan. 1996. Herpes simplex virus type 2 inhibition of Fas ligand expression. J. Virol. 70:8747-8751.
Sinclair, J. and P. Sissons. 1996. Latent and persistent infection of monocytes and macrophages. Intervirol. 39:293-301.
Smyth, M. J., and J. A. Trapani. 1995. Granzymes: exogenous proteinases that induces target cells apoptosis. Immunol. Today 16:202-206.
Soengas, M. S., R. M. Alarcón, H. Yoshida, A. J. Giaccia, R. Hakem, T. W. Mak and S. W. Lowe. 1999. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science. 284:156-159.
Tewari, M. and V. M. Dixit. 1995. Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol. Chem. 270:3255- 3260.
Thome, M., P. Schneider, K. Hofmann, H. Fickenscher, E. Meinl, F. Neipel, C. Mattman, K. Burns, J. L. Bodmer, M. Schröter, C. Scaffidi, P. H. Krammer, M. E. Peter and J. Tschopp. 1997. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386:517-521.
Tollefson, A. E., T. W. Hermiston, D. L. Lichtenstein, C.F. Colle, R. A. Trip, T. Dimitrov, K. Toth, C. E. Wells, P.C. Doherty and W. S. Wold. 1998. Forced degradation of Fas inhibits apoptosis in adenovirusinfected cells. Nature 392:726-730.
Vilcek, J. and G. C. Sen. 1996. Interferons and other cytokines. In: B. N. Fields, Knipe D. M. and P. M. Howley (ed). Fundamental Virology. Third ed. Lippincot- Raven Publishers.
Virgin, H. W., P. Latreille and P. Wamsley. 1997. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J. Virol. 71:5894-5904.
Wang, G. H., J. Bertin and Y. Wang. 1997. Bovine herpesvirus 4 BORFE2 protein inhibits Fas- and tumor necrosis factor receptor 1-induced apoptosis and contains death effector domains shared with other gamma- 2 herpesviruses. J. Virol. 71:8928-8932.
Xue, D. and H. R. Horvitz. 1995. Inhibition of the Caenorhabditis elegans cell-death protease CED -3 by a CED-3 cleavage site in baculovirus p35 protein. Nature 377:248-251.
York, I. A. and K. L. Rock. 1996. Antigen processing and presentation by the class I major histocompatibility complex. Annu. Rev. Immunol. 14:369-396.
Yoshida, H., H. Sumichika, S. Hamano, X. He, Y. Minamishima, G. Kimura and K. Nomoto. 1995. Induction of apoptosis of T cells by infecting mice with mu rine cytomegalovirus. J. Virol. 69:4769-4775.
Zhou, Q., S. Snipas, K. Orth, M. Muzio, V. M. Dixit, G. S. Salvesen. 1997. Target protease specificity of the viral serpin CrmA. Analysis of five caspases. J. Biol. Chem. 272:7797-7800.
Zhu, H, Y. Shen and T. Shenk. 1995. Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J. Virol. 69:7960-7970.